Form 4 holding
10%+ Owner
Fulcrum Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,343,154
- Estimated value
- $7,755,840
- Report date
- 13 Dec 2022
- Price
- $3.31
- Ownership
- Indirect
Third Rock Ventures III, L.P. - 10%+ Owner at Fulcrum Therapeutics, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- FULC on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Third Rock Ventures III, L.P. since 26 Aug 2025
Reported holdings for Third Rock Ventures III, L.P. in Fulcrum Therapeutics, Inc.
Form 4 holding
10%+ Owner
Fulcrum Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,962,202
- Estimated value
- $6,494,889
- Report date
- 13 Dec 2022
- Price
- $3.31
- Ownership
- Direct
Transaction history for Third Rock Ventures III, L.P. in Fulcrum Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.